The Conversation (0)
Minneapolis, MN, Aug. 17, 2016 (GLOBE NEWSWIRE) — BioSig Technologies (OTCQB:BSGM), a medical device company developing the PURE EP(TM) System, a novel cardiac electrophysiology (EP) information system, today announced its submission entitled “Enhanced Electrophysiology Recording System” will be presented on Friday, August 19, 2016 at the 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC 2016).
Minneapolis, MN, Aug. 17, 2016 (GLOBE NEWSWIRE) — BioSig Technologies (OTCQB:BSGM), a medical device company developing the PURE EP(TM) System, a novel cardiac electrophysiology (EP) information system, today announced its submission entitled “Enhanced Electrophysiology Recording System” will be presented on Friday, August 19, 2016 at the 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC 2016). The presentation will be held in Pastoral 1 (Session FrCT8) at the Contemporary Resort in Orlando, Florida with a poster session to follow.
Commenting on the milestone, Jay Millerhagen, VP of Clinical Research, said, “We are honored our work was accepted by the editors for the prestigious EMBC 2016 Conference. This submission together with the recent article in JACC: Cardiac Electrophysiology represent significant milestones further validating the PURE EP System’s performance in pre-clinical trials.”
Connect with BioSig Technologies (OTCQB:BSGM) to receive an Investor Presentation.